# US 2021/0069183 A1 · Composition containing piperacillin, pharmaceutical formulation thereof and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0069183 A1
- Document ID: US20210069183A1
- Status: Published application
- Kind: A1
- Application number: 16/771,429
- Filed: 2017-12-25
- Published: 2021-03-11
- Earliest claimed: 2017-12-25
- Assignees: Xiangbei Welman Pharmaceutical Co., Ltd
- Applicants: Xiangbei Welman Pharmaceutical Co., Ltd.
- Inventors: Tianyu SUN
- Web page: https://patentgrep.com/patent/US20210069183A1

## CPC

- A61K 31/496: Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 9/19: lyophilised {, i.e. freeze-dried, solutions or dispersions (lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00)}
- A61K 31/43: Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula [IMAGE cpc-sch-A61K-0952.gif], e.g. penicillins, penems
- A61K 47/02: Inorganic compounds
- A61P 31/04: Antibacterial agents
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present disclosure provides a piperacillin-containing composition, which further containing a certain proportion of ampicillin and sulbactam. The present disclosure further provides a pharmaceutical formulation thereof and the use thereof. The composition and pharmaceutical formulation of the present disclosure can inhibit the drug-resistant Acinetobacter baumannii, and particularly have therapeutic effects on the infection caused by Acinetobacter baumannii which is resistant to carbapenem or cefoperazone-sulbactam.

## Claims

### Claim 1

A piperacillin-containing composition, comprising ampicillin and sulbactam, wherein the composition comprises piperacillin, ampicillin and sulbactam in a weight ratio of 200-400:0.02-6:100.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the composition comprises piperacillin, ampicillin and sulbactam in a weight ratio of 200-400:0.02-3:100, or in a weight ratio of 200-400:0.04-6:100.

### Claim 3 (depends on 1)

The composition according to claim 1, the composition consists of piperacillin, ampicillin and sulbactam.

### Claim 4 (depends on 1)

A pharmaceutical formulation comprising the composition according to claim 1.

### Claim 5 (depends on 4)

The pharmaceutical formulation according to claim 4, wherein the pharmaceutical formulation is an injection.

### Claim 6 (depends on 5)

The pharmaceutical formulation according to claim 5, wherein the injection is a powder for injection or a solution for injection.

### Claim 7 (depends on 6)

The pharmaceutical formulation according to claim 6, wherein the powder for injection is a sterile powder for injection or lyophilized powder for injection.

### Claim 8 (depends on 1)

A method for treating a bacterial infection disease, comprising administering the composition according to claim 1.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the bacteria is drug-resistant Acinetobacter baumannii.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the drug-resistant Acinetobacter baumannii is resistant to cefoperazone-sulbactam.

### Claim 11 (depends on 8)

The method according to claim 8, wherein the composition is formulated to a pharmaceutical formulation.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the pharmaceutical formulation is an injection.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the injection is a powder for injection or a solution for injection.
